Global biotech supplier of cell culture media, separation tools, and research instruments
STEMCELL Technologies manufactures and distributes specialized products for stem cell, immunology, cancer, and regenerative medicine research across 70+ countries. The company is Canada's largest biotech operator by headcount, with a 1,000+ person workforce and a tech stack anchored in SAP (ERP + IBP), Salesforce, Snowflake, and Tableau — a classic manufacturing-to-distribution infrastructure. Recent hiring acceleration in sales and support signals expansion of customer-facing operations, while active projects around pricing tooling (Snowflake + Streamlit), supply chain enhancement, and production optimization reflect internal operational scaling.
Founded in 1993, STEMCELL Technologies is a privately held Canadian biotech company headquartered in Vancouver, BC, with over 2,000 employees globally. The company manufactures and supplies cell culture media, cell separation products, instruments, software, and contract research services to life science institutions worldwide. Products span stem cell detection kits, antibodies, primary cells, cytokines, and cryopreservation media. Distribution is managed through regional offices and dedicated centers in Vancouver, Seattle, Grenoble, and Singapore, serving research labs in more than 70 countries. The workforce is predominantly composed of scientists and engineers, reflecting the technical depth required for product development and customer support.
SAP (ERP and IBP), Salesforce, Snowflake, Tableau, Streamlit, Python, SQL, COMSOL, ANSYS, Jira, and Microsoft Office suite. Recent projects include pricing tool development in Snowflake and Streamlit.
Four global hubs: Vancouver (HQ), Seattle, Grenoble, and Singapore. The company also operates regional offices and serves 70+ countries.
Other companies in the same industry, closest in size